FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/12/060697 [Registered on: 22/12/2023] Trial Registered Prospectively
Last Modified On: 19/12/2023
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   Development and exploring the effect of Paediatric Palliative Care services embedded within the Paediatric Oncology care setting  
Scientific Title of Study   Embedded Model of Integrated Paediatric Palliative Care in Paediatric Oncology: Development and Testing its Effectiveness. (EMANCIPATION Study)  
Trial Acronym  EMANCIPATION 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Naveen Salins 
Designation  Professor and Head of Department 
Affiliation  Kasturba Medical College, Manipal, Manipal Academy of Higher education, Manipal 
Address  Department of Palliative Medicine and Supportive care, Room no 4, Manipal Comprehensive cancer care centre, Shirdi Sai Cancer Block, Kasturba Hospital, Eshwar Nagar,Manipal

Udupi
KARNATAKA
576104
India 
Phone  08202922221  
Fax    
Email  naveensalins@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Naveen Salins 
Designation  Professor and Head of Department 
Affiliation  Kasturba Medical College, Manipal, Manipal Academy of Higher education, Manipal 
Address  Department of Palliative Medicine and Supportive care, Room no 4, Manipal Comprehensive cancer care centre, Shirdi Sai Cancer Block, Kasturba Hospital, Eshwar Nagar,Manipal

Udupi
KARNATAKA
576104
India 
Phone  08202922221  
Fax    
Email  naveensalins@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Naveen Salins 
Designation  Professor and Head of Department 
Affiliation  Kasturba Medical College, Manipal, Manipal Academy of Higher education, Manipal 
Address  Department of Palliative Medicine and Supportive care, Room no 4, Manipal Comprehensive cancer care centre, Shirdi Sai Cancer Block, Kasturba Hospital, Eshwar Nagar,Manipal

Udupi
KARNATAKA
576104
India 
Phone  08202922221  
Fax    
Email  naveensalins@gmail.com  
 
Source of Monetary or Material Support  
Indian Council of Medical Research,New Delhi 
 
Primary Sponsor  
Name  Indian Council of Medical Research 
Address  V. Ramalingaswami Bhawan, P.O. Box No. 4911 Ansari Nagar, New Delhi - 110029, India 
Type of Sponsor  Government funding agency 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 3  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Veronique Dinand  Bai Jerbai wadia Hospital for Children  Acharya Donde Marg, Parel, Mumbai, 400014
Mumbai
MAHARASHTRA 
9971839244

verodinand@gmail.com 
Dr Naveen Salins  Kasturba Medical College and Kasturba Hospital, Manipal  Eshwar Nagar, Manipal, 576104
Udupi
KARNATAKA 
08202922221

naveensalins@gmail.com 
Dr Gayatri Palat  MNJ Institute of Oncology and Regional cancer Centre  11-5, 399red hills, Red Hills, Lakdikapul, Hyderabad 500004
Hyderabad
TELANGANA 
9985480614

gpalat@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 3  
Name of Committee  Approval Status 
Bai Jerbai Wadia Childrens Hospital  Approved 
Kasturba Medical College and Kasturba Hospital, Institutional Ethics Committee  Approved 
MNJ Institute of Oncology and Regional Cancer Centre  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: C00-D49||Neoplasms,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  1.00 Day(s)
Age To  18.00 Year(s)
Gender  Both 
Details  1) All children age of 18 years and below, 2) Children diagnosed with cancer, 3)New or Follow up cases of Childhood cancer patients, 4) Children with cancer in both IPD & OPD setting.
 
 
ExclusionCriteria 
Details  1) Children following up with pediatric oncology services, in cancer remission.
2) Refusal of consent from parents and assent from adolescent children. 
 
Method of Generating Random Sequence    
Method of Concealment    
Blinding/Masking    
Primary Outcome  
Outcome  TimePoints 
Identifying Palliative care needs in children with cancer using Paediatric Palliative Care Scale (PaPaS) screening tool. Score   1 baseline visit (T0) 
 
Secondary Outcome  
Outcome  TimePoints 
Identifying the symptom burden in children with cancer at presentation to paediatric oncology   1 baseline visit (t0) 
 
Target Sample Size   Total Sample Size="150"
Sample Size from India="150" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   31/12/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Annually world-wide 300,000 children are detected with cancer, 90% of them live in low and middle-income countries. Children in low-income countries have a cure rate of 30-50%.  Around 4.2 million children need palliative care in India, but only small percentage of children are referred and often referred late. Palliative care in a paediatric oncology setting is known to improve pain, symptoms, quality of life and end of life support. According to the studies conducted by Brock 2021, Farooki 2021 and Falk 2021 (all USA), the embedded paediatric palliative oncology models demonstrated a higher number of children accessing palliative care, longer stay with the palliative care service before death, and fewer days in the hospital during the last three months of their lives and enabled better acceptance of paediatric palliative care by the paediatric oncologists. However, this model is never tested outside of United States and considering the dismal rate of palliative care access to children in India (<0.5%), the results of this study might influence future policy and practice. The key expected outcome is to identify the palliative care needs in children with cancer in a paediatric oncology care setting.

 
Close